- Home
- MREO vs TCMD Comparison
MREO vs TCMD Comparison
Compare MREO & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- TCMD
- Stock Information
- Founded
- MREO 2015
- TCMD 1995
- Country
- MREO United Kingdom
- TCMD United States
- Employees
- MREO N/A
- TCMD N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- TCMD Medical/Dental Instruments
- Sector
- MREO Health Care
- TCMD Health Care
- Exchange
- MREO Nasdaq
- TCMD Nasdaq
- Market Cap
- MREO 424.5M
- TCMD 314.0M
- IPO Year
- MREO N/A
- TCMD 2016
- Fundamental
- Price
- MREO $2.41
- TCMD $9.54
- Analyst Decision
- MREO Strong Buy
- TCMD Hold
- Analyst Count
- MREO 7
- TCMD 3
- Target Price
- MREO $7.71
- TCMD $16.00
- AVG Volume (30 Days)
- MREO 1.5M
- TCMD 317.5K
- Earning Date
- MREO 05-19-2025
- TCMD 05-05-2025
- Dividend Yield
- MREO N/A
- TCMD N/A
- EPS Growth
- MREO N/A
- TCMD N/A
- EPS
- MREO N/A
- TCMD 0.66
- Revenue
- MREO N/A
- TCMD $293,164,000.00
- Revenue This Year
- MREO N/A
- TCMD $10.68
- Revenue Next Year
- MREO $56.11
- TCMD $8.82
- P/E Ratio
- MREO N/A
- TCMD $14.45
- Revenue Growth
- MREO N/A
- TCMD 5.96
- 52 Week Low
- MREO $1.58
- TCMD $8.61
- 52 Week High
- MREO $5.02
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- MREO 50.36
- TCMD 20.45
- Support Level
- MREO $2.28
- TCMD $8.61
- Resistance Level
- MREO $2.75
- TCMD $14.22
- Average True Range (ATR)
- MREO 0.16
- TCMD 0.48
- MACD
- MREO -0.00
- TCMD -0.51
- Stochastic Oscillator
- MREO 27.66
- TCMD 15.50
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.